FDA Clearance Tracker · P840001-S469
Restore, Itrel, Synergy, Intellis, and Vanta Spinal Cord Stimulation Systems, Pisces, Specify and Vectris Spinal Cord St
Last checked: Nov 20, 2026Latest source record: Jan 21, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Jan 21, 2022
Approved
Time to decision
164 days
Received Aug 10, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P840001-S469
- Device name
- Restore, Itrel, Synergy, Intellis, and Vanta Spinal Cord Stimulation Systems, Pisces, Specify and Vectris Spinal Cord St
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Aug 10, 2021
- Decided
- Jan 21, 2022
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P840001
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for expanding the indications to include the management of chronic intractable pain of the lower limbs, including unilateral or bilateral pain, due to diabetic peripheral neuropathy of the lower extremities.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.